ClinicalTrials.Veeva

Menu

Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia (INFINITY)

O

Osaka University

Status

Unknown

Conditions

Hyperalphalipoproteinemia
Hyper-LDL-cholesterolemia
Low CETP Activity
CETP Deficiency
High Level of Remnant Cholesterol

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01916512
INFINITY

Details and patient eligibility

About

The aim of this study is to determine whether high high density lipoprotein-cholesterol(HDL-C) level and low Cholesteryl Ester Transfer Protein(CETP) activity is atherogenic or not in subjects who received health checkups. We investigate the association between CETP activities and the severity of atherosclerosis assessed by intima-media thickness (IMT) and compare the atherogenic change between in subjects with high HDL-C level, low HDL-C level, high CETP activities and low CETP activities by examining the morbidity rate of atherogenic diseases, the rate of ischemic electrocardiography(ECG) change, Calc Score of artery from chest X-ray, Ankle Brachial Index/Pulse Wave Velocity and various serum atherogenic markers. And we also examine the correlation between normal lipid profile and concentration, activity and function of surface lipoprotein in subjects with variety of lipoprotein levels, including patients with hyper-LDL-cholesterolemia, hyper-HDL-cholesterolemia with low or no CETP activity, patients with high level of remnant cholesterol or hyperlipoproteinemia of apolipoprotein(Apo)B-48.

Enrollment

1,500 estimated patients

Sex

All

Ages

40 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Subjects who are at the age of 40 and above and undergo annual health check in Omagari area including Daisen city and Yokote city and who provide written informed consent.

Exclusion criteria

  1. Those who do not provide written informed consent.
  2. Those who are not able to take tests.
  3. Those who are regarded not adequate as subject of this study by their physicians.

Trial contacts and locations

1

Loading...

Central trial contact

Daisaku Masuda, MD, PhD; Shizuya Yamashita, MD, PhD, FAHA, FJCC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems